XML 33 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727
Note 6 - Stock Option Plan
9 Months Ended
Jun. 30, 2015
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note
6 – Stock Option Plan
 
Plan Information
 
At the annual meeting of shareholders in March 2015, the shareholders approved the 2015 Incentive Stock Plan (the “Plan”). The Plan provides for awards of stock options and restricted stock to officers, directors, key employees and consultants. The Plan provides an additional 500,000 shares of common stock available for issuance in addition to those stock awards that were outstanding under the previous incentive stock plan. Under the Plan, option prices will be set by the Compensation Committee and may not be less than the fair market value of the stock on the grant date.
 
At June 30, 2015, 1,100,591 shares of common stock were reserved for stock award grants under the Plan. Of these reserved shares, 500,000 shares were available for future grants.
 
Stock Options
 
All share-based payments to employees, including grants of employee stock options, are recognized in the financial statements based on their grant date fair value over the requisite service period. Compensation expense for share-based awards is included in the operating, selling, general and administrative expense section of the Company’s consolidated condensed statements of operations.
 
Stock options are valued at the date of the award, which does not precede the approval date, and compensation cost is recognized on a straight-line basis over the vesting period. Stock options granted to employees generally become exercisable over a three, four or five-year period from the date of grant and generally expire ten years after the date of grant. Stock options granted to the Board of Directors generally become exercisable on the date of grant and generally expire ten years after the grant.
 
A summary of the status of the Company's stock options at June 30, 2015 and changes during the nine months then ended is presented below:
 
   
Shares
   
Wtd. Avg.
Ex. Price
 
Outstanding at September 30, 2014
    560,000     $ 2.96  
Granted
           
Exercised
           
Expired
    (15,000 )   $ 4.62  
Forfeited
           
Outstanding at June 30, 2015
    545,000     $ 2.91  
                 
Exercisable at June 30, 2015
    311,667     $ 2.94  
 
No nonqualified stock options were granted for the nine months ended June 30, 2015. The Company estimates the fair value of the options granted using the Black-Scholes option valuation model. The Company estimates the expected term of options granted based on the historical grants and exercises of the Company’s options. The Company estimates the volatility of its common stock at the date of the grant based on both the historical volatility as well as the implied volatility on its common stock. The Company bases the risk-free rate that is used in the Black-Scholes option valuation model on the implied yield in effect at the time of the option grant on U.S. Treasury zero-coupon issues with equivalent expected term. The Company has never paid cash dividends on its common stock and does not anticipate paying cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of zero in the Black-Scholes option valuation model. The Company amortizes the resulting fair value of the options ratably over the vesting period of the awards. The Company uses historical data to estimate the pre-vesting option forfeitures and records share-based expense only for those awards that are expected to vest.
 
Compensation expense related to unvested stock options recorded for the nine months ended June 30, 2015 is as follows:
 
   
Nine Months Ended
 
   
June 30, 2015
 
Fiscal year 2012 grant
  $ 24,783  
Fiscal year 2014 grant
  $ 81,468  
 
The Company records compensation expense over the vesting term of the related options. At June 30, 2015, compensation costs related to these unvested stock options not yet recognized in the consolidated condensed statements of operations was $119,288.
 
Restricted Stock
 
The Company granted restricted stock in March 2015 to its Board of Directors totaling 31,915 shares, which were valued at market value on the date of grant. The shares are being held by the Company for 12 months and will be delivered to the directors at the end of the 12 month holding period. The fair value of these shares upon issuance totaled $75,000 and is being amortized over the 12 month holding period as compensation expense. The Company granted restricted stock in April of 2014 to certain employees totaling 23,676 shares, which were valued at market value on the date of grant. The shares have a holding restriction, which will expire in equal annual installments of 7,892 shares over three years starting in April 2015. The fair value of these shares upon issuance totaled $76,000 and is being amortized over the respective one, two and three year holding periods as compensation expense. The unamortized portion of the restricted stock is included in prepaid expenses on the Company’s consolidated condensed balance sheets.